| Product Code: ETC9513040 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Suriname saw a significant increase in H1N1 vaccine import shipments in 2024, with top exporters being Brazil, India, USA, Netherlands, and France. The market concentration, measured by the Herfindahl-Hirschman Index (HHI), reached very high levels, indicating a more consolidated market. The compound annual growth rate (CAGR) from 2020 to 2024 was robust at 10.35%, with a remarkable growth rate of 111.98% from 2023 to 2024. This suggests a rapidly expanding market for H1N1 vaccines in Suriname, driven by strong demand and increased import activities from key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname H1N1 Vaccines Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname H1N1 Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname H1N1 Vaccines Market - Industry Life Cycle |
3.4 Suriname H1N1 Vaccines Market - Porter's Five Forces |
3.5 Suriname H1N1 Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Suriname H1N1 Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Suriname H1N1 Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Suriname H1N1 Vaccines Market Trends |
6 Suriname H1N1 Vaccines Market, By Types |
6.1 Suriname H1N1 Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname H1N1 Vaccines Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Suriname H1N1 Vaccines Market Revenues & Volume, By Inactivated Vaccine, 2021- 2031F |
6.1.4 Suriname H1N1 Vaccines Market Revenues & Volume, By Live Attenuated Vaccine, 2021- 2031F |
6.2 Suriname H1N1 Vaccines Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Suriname H1N1 Vaccines Market Revenues & Volume, By Intradermal Vaccines, 2021- 2031F |
6.2.3 Suriname H1N1 Vaccines Market Revenues & Volume, By Intramuscular Vaccines, 2021- 2031F |
6.2.4 Suriname H1N1 Vaccines Market Revenues & Volume, By Intranasal Vaccines, 2021- 2031F |
7 Suriname H1N1 Vaccines Market Import-Export Trade Statistics |
7.1 Suriname H1N1 Vaccines Market Export to Major Countries |
7.2 Suriname H1N1 Vaccines Market Imports from Major Countries |
8 Suriname H1N1 Vaccines Market Key Performance Indicators |
9 Suriname H1N1 Vaccines Market - Opportunity Assessment |
9.1 Suriname H1N1 Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Suriname H1N1 Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Suriname H1N1 Vaccines Market - Competitive Landscape |
10.1 Suriname H1N1 Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Suriname H1N1 Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |